From small-scale stem cell production to large-scale hiPSC-based drug development: The flexibility of stirred-tank bioreactors.

Stirred-tank bioreactors are gaining more and more importance in the industrial production of pharmaceutical products, biofuels and food. When compared with 2D-cultivation systems, bioreactors are easy to handle, and multiple bioreactors can be controlled in parallel without a considerable increase of workload. In stirred-tank bioreactors cells can be cultivated as free cells in solution, cell aggregates or on microcarriers in batch, fed-batch or continuous cultivation modes.

Date & Time:
Monday, September 16, 2019 at 9am EDT| 2pm BST| 3pm CEST

Duration (optional):
1 hour

Ankita Desai, Bioprocess Field Application Specialist, Eppendorf North America
Dr. Arie Reijerkerk, Head of Services and Innovation, Ncardia
Dr. Farbod Famili, Project leader assay development and high-throughput screening Ncardia

Key Learning Objectives:

  • Learn about the challenges and benefits of stirred-tank bioreactors.
  • Receive insights on the different impeller types and their geometry on cell growth.
  • Learn about the benefits and challenges of up-scaling a bioreactor process.
  • Learn about the application of controlled bioreactor processes to drug discovery and development.
  • Get the chance to interact with experts in a live Q&A session.

More information

Ankita Desai
Dr. Farbod Famili
Dr. Arie Reijerkerk

From Cell Seeding to Analysis - Getting the Best Out of Your Cell-based Assay

Do you want to know how to increase the reproducibility of your cell-based assays and get practical advice on how to avoid common pitfalls? Don't miss our free new webinar including live Q&A session.

Learning Objectives:

  • How to find the best time point for analysis
  • What are the pros/cons of the different modes of detection?
  • Tips and tricks for optimal cell culture routine and assay setup


Date & Time:
September 10, 2019 at 3:00pm CET, 06:00am PT, 09:00am ET

Jessica Wagener, Ph.D., Application Specialist Cell Handling, Eppendorf AG
Erik Bonke, Ph.D., Application Specialist, Promega GmbH

More information

Jessica Wagener, Ph.D
Erik Bonke, Ph.D

The bread and butter method of genomics: How to improve your (q)PCR

PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides its age of 36 years it is still a core component of numerous complex applications. The PCR is the workhorse method in virtually every molecular biology laboratory and the gold standard in countless analytical assays. Despite its broad usage, there are several factors that need to be considered to design a successful PCR experiment. Starting from more apparent things like temperature settings and DNA template quality to less known factors as pipetting techniques and used consumables, this webinar covers multiple ways to improve your PCR. In addition, we will also take a closer look at the special requirements of qPCR as probably the most commonly used variant of traditional PCR. 

Learning Objectives 

  • Pain points and solutions of (q)PCR setup
  • Correct (q)PCR setup
  • Tips and tricks for (automated) pipetting of a PCR setup

Date & Time:
September 5, 2019 at 7:00am PT, 10:00am ET, 4:00pm CEST

Tim Schommartz, Ph.D.
Application Specialist Liquid Handling, Eppendorf AG

More information

Tim Schommartz, Ph.D.

Implementation of an Affordable and Scalable Manufacturing Strategy for Gene Therapy Products

As a start up with multiple clinical programs within an accelerated track MeiraGTx started designing our processes and aimed to build facilities to ensure therapeutic drug products reach patients as quickly as possible. As scientists and as people this tends to be the main goal, and although there are many challenges to commercializing a therapeutic drug product this is only the first step. To be able to continually serve patients, the company must be set up in a way to be sustainable throughout the clinical phase until revenue can be generated via commercial sales. Understanding the patient and company needs are a key cornerstone for having successful products and a successful company transition from clinical to commercial products. Within this presentation Bastian Leewis will illustrate and explain the approach chosen by MeiraGTx for some of the platform components.

Date & Time:
September 25, 2019 at 10 a.m. EDT / 3 p.m. GMT / 4 p.m. CEST

Bastiaan Leewis, MSAT Manager of Industrialization at MeiraGTx
Ankita Desai, Bioprocess Field Application Specialist at Eppendorf North America

More information

Ankita Desai
Bastiaan Leewis